In its round-up of the of the International Conference on Family Planning Kigali, Rwanda, Devex cited two of the Council’s contraceptive innovations as major highlights of the 2018 conference.
This week, more than 40 Population Council staff from 12 countries are presenting research finding that advances access to quality family planning services and products at the International Conference on Family Planning (ICFP) in Kigali, Rwanda. Co-hosted by the Bill & Melinda Gates Institute for Population and Reproductive Health and the Ministry of Health of the Republic of Rwanda, ICFP 2018 is bringing together thousands from the family planning community to share best practices, celebrate successes, and chart a course forward.
_211_141.jpg)
NEW YORK, NEW YORK (November 14, 2018) ̶ The Population Council has received initial funding from the Children’s Investment Fund Foundation (CIFF) to assess the feasibility of combining oral pre-exposure prophylaxis (PrEP) for HIV prevention with an oral contraceptive into a single pill, which women would take once a day.
In response to a New York Times editorial by columnist Ross Douthat, Population Council Vice President and Distinguished Scholar John Bongaarts pens a letter to the editor promoting women's ability to plan their own futures and the work of international family planning organizations to help make that possible.
October 24, 2018 -- Population Council researchers presented new evidence on promising biomedical and behavioral strategies to prevent HIV and other sexually transmitted infections at the HIV Research for Prevention (HIVR4P) conference in Madrid this week, the world’s only scientific meeting dedicated exclusively to biomedical HIV prevention.
The Population Council congratulates Irving Sivin, a recipient of the Society of Family Planning Lifetime Achievement Award and a former senior scientist at the Center for Biomedical Research at the Population Council. The award recognizes Sivin for his commitment to family planning research.
New York, NY, 18 Oct. 2018 – Régine Sitruk-Ware, MD, distinguished scientist at the Population Council’s Center for Biomedical Research, has been named by TIME Magazine as one of the 50 Most Influential People in Health Care of 2018. Dr. Sitruk-Ware is being recognized for her research and leadership, which led to the recent U.S. FDA approval of Annovera™ (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive that provides an entire year of protection against unintended pregnancy while fully under a woman’s control.
At The Conversation, Council researcher Karen Austrian discussed how the Adolescent Girls Initiative-Kenya (AGI-K) program is reaching vulnerable girls in urban and rural communities who are at risk of dropping out of school, sexual violence and early sexual initiation, early and unintended pregnancy, and early marriage.
_211_141.jpg)
September 24, 2018 – New research by the Population Council and partners shows that it may be possible to formulate a discreet, convenient, and woman-controlled multi-purpose technology to prevent HIV and other sexually transmitted infections (STIs) with limited risk of cross-resistance to antiretrovirals (ARV). This research published today in Nature Communications tests the non-antiretroviral agents, griffithsin (GRFT) and carrageenan (CG), in a fast-dissolving vaginal insert in rhesus macaques and mice.
In a video interview, Judith Bruce explains that financial concerns can take much of the sentimentality and romance out of marriage.
